Role of diabetes in heart rhythm disorders

Buelent Koektuerk1, Murat Aksoy1, Marc Horlitz1

  • 1Buelent Koektuerk, Murat Aksoy, Marc Horlitz, Ramazan Goekmen Turan, Department of Cardiology/Electrophysiology, Witten/Herdecke University, Krankenhaus Porz am Rhein, 58448 Cologne, Germany.

World Journal of Diabetes
|February 11, 2016
PubMed

Insights

Diabetes mellitus (DM) significantly increases cardiovascular disease risk, leading to complications like atherosclerosis and arrhythmias. This overview explores the link between DM and heart rhythm disorders, including atrial fibrillation and ventricular arrhythmias.

Area of Science:

  • Cardiology
  • Endocrinology
  • Clinical Medicine

Background:

  • Diabetes mellitus (DM) incidence is rapidly increasing globally.
  • DM is a primary driver of cardiovascular diseases (CVDs), exacerbating atherosclerosis.
  • DM independently elevates risks for macrovascular and microvascular complications, including myocardial infarction, stroke, and retinopathy.

Purpose of the Study:

  • To provide a concise overview of the association between DM and cardiac rhythm disorders.
  • To elucidate the underlying pathophysiological mechanisms linking DM to arrhythmias.
  • To highlight DM as a critical risk factor for cardiovascular morbidity and mortality.

Main Methods:

  • Literature review of studies on diabetes and cardiac arrhythmias.
  • Analysis of pathophysiological mechanisms connecting DM to atrial fibrillation (AF) and ventricular arrhythmias (VA).
  • Synthesis of current understanding on DM's impact on cardiovascular health and rhythm disturbances.

Main Results:

  • DM is strongly associated with increased prevalence of atrial fibrillation (AF) and ventricular arrhythmias (VA).
  • Aggravated atherosclerosis and macro/microangiopathy in DM patients contribute to cardiac complications.
  • DM significantly increases cardiovascular morbidity and mortality, often linked to rhythm disorders.

Conclusions:

  • Diabetes mellitus poses a substantial threat to cardiovascular health, markedly increasing the risk of arrhythmias.
  • Understanding the pathophysiological links between DM and disorders like AF and VA is crucial for patient management.
  • Effective DM management is essential to mitigate associated cardiovascular risks and improve patient outcomes.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.6K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.5K
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
779
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
471
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
612